Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners
Sophia Stock, Anna-Kristina Kluever, Stefan Endres, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 307-307
Open Access | Times Cited: 19

Showing 19 citing articles:

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 792
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 60
A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: from molecular interactions to potential therapeutic targets
Mina Alimohammadi, Payman Rahimzadeh, Ramin Khorrami, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155401-155401
Closed Access | Times Cited: 9
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function
Matthias Seifert, Mohamed-Reda Benmebarek, Daria Briukhovetska, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 12, pp. 2175-2185
Open Access | Times Cited: 23
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control
Sophia Stock, Anna‐Kristina Klüver, Luisa Fertig, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 10, pp. 1706-1725
Open Access | Times Cited: 14
MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB
Xiu‐Jian Wang, Tao Xiao, Pengjie Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors
Anne Holtermann, Mila Gislon, Martin K. Angele, et al.
BioDrugs (2024) Vol. 38, Iss. 5, pp. 611-637
Open Access | Times Cited: 4
Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies
Laura H. Porter, Sophie Harrison, Gail P. Risbridger, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 243, pp. 106571-106571
Open Access | Times Cited: 3
MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells
Seyed Mohammad Ali Hosseini Rad, Joshua Colin Halpin, Supannikar Tawinwung, et al.
Immunology and Cell Biology (2022) Vol. 100, Iss. 6, pp. 424-439
Open Access | Times Cited: 12
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment
Duc Huynh, Pia Winter, Florian Märkl, et al.
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 215-227
Open Access | Times Cited: 12
Multiple Myeloma: Possible Cure from the Sea
Anita Capalbo, Chiara Lauritano
Cancers (2022) Vol. 14, Iss. 12, pp. 2965-2965
Open Access | Times Cited: 8
Evolution by innovation as a driving force to improve TCR-T therapies
Dolores J. Schendel
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies
Ogochukwu Izuegbuna
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 5
Nanotechnology-enhanced immunotherapy for cancer
Akshata R. Naik
Elsevier eBooks (2024), pp. 297-307
Closed Access
Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research
Sophia Stock, Luisa Fertig, Vivien D. Menkhoff, et al.
Methods in cell biology (2024), pp. 329-352
Closed Access
The role of cellular persistence in CAR T cell therapy
Vivien D. Menkhoff, Sophie Bernhard, Stefanos Michaelides, et al.
Elsevier eBooks (2024)
Closed Access
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors
Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
BioDrugs (2024)
Open Access
Aurora kinase inhibitors regulate T memory stem cell phenotype in T cell receptor-engineered T cells with prolonged persistence
Linglu Yi, Yu Ma, Xiao Liang, et al.
Research Square (Research Square) (2023)
Open Access
Updating CAR-T Cell Immunotherapy for Liquid and Solid Tumor
Ankita Singh, Pravin D. Potdar
Diseases & Research (2023) Vol. 3, Iss. 2, pp. 110-120
Open Access
Page 1

Scroll to top